Report on First International Conference on Clinical Sciences and Drug Discovery (CSDD-2015)
International conference on Clinical Sciences and Drug Discovery has successfully concluded on November 04, 2015 at Baltimore, USA. This distinctive conference brought together the senior level experts with a perfect blend for multidisciplinary collaboration between clinicians, innovators, scientists, academicians from all over the world and discussed the latest breakthroughs in the fields of clinical sciences and drug development.
This pinnacle perceived 6 keynote presentations and 40 oral presentations on various topics related to drug discovery and clinical sciences.
Day 1 of the conference was initiated by distinguished speaker Dr. Terry Stouch, PhD, President of Science for Solutions, LLC., with an excellent speech on “The errors of our ways: accounting for known unknowns in drug discovery research”.
The program was continued by Dr. Harold Smith, a tenured professor of biochemistry and biophysics at the University of Rochester, School of Medicine and Dentistry, who spoke about, “Going beyond repurposing cancer drugs: identification of novel HIV drug leads that are broadly neutralizing of HIV1 clades and drug-resistant strains”.
The last keynote presentation of the day was by Dr. Nikolai Zhelev, Professor of Medical Biotechnology and Director of CMCBR at Abertay University, Dundee, Scotland on “Recent advances and novel approaches in the discovery and development of cyclin-dependent kinase inhibitors as new therapeutics in oncology and cardiology”. This was followed by featured presentations session chaired by Dr. Smith, University of Rochester, USA and Dr. Ram Samudrala, State University of New York, USA.
Day 2 started with an energetic speech by Prof. Hiroshi Maeda, Sojo University, Japan on “Toward full understanding of the EPR effect in primary and metastatic tumor, and issues of heterogeneity: for tumor selective delivery and imaging using nano-particles”. This was followed by another keynote speech on “Discovering quality drug seeds by practical NMRbased fragment screening” by Prof. Steven LaPlante, faculty member at the University of Quebec INRSIAF, founder of NMX Research and Solutions. The last keynote presentation was delivered by Prof. Dawei Li on “Monoclonal antibody targeting of tumour micro environment”. Day 2 ended with featured oral presentations sessions chaired by Prof. Zhelev.
With some eloquent talks on Day 3, the featured presentations session was chaired by Profs. LaPlante and Maeda. CSDD-2015 concluded with honoring the speakers with awards and certificates.
